Advanced search
Publication Cover
Ocular Immunology and Inflammation Volume 28, 2020 - Issue 4
Submit an article Journal homepage
158
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Ectodermal Dysplasia: Association with Anti-Basement Membrane Autoantibodies

Francisco Lucero SaáDepartment of Ophthalmology, Hospital de Clínicas José de San Martin, Universidad de Buenos Aires (UBA), Buenos Aires, ArgentinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9403-461X
ORCID Icon,
Federico Andrés CremonaDepartment of Ophthalmology, Hospital de Clínicas José de San Martin, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina
,
Natalia Ximena MínguezDepartment of Ophthalmology, Hospital de Clínicas José de San Martin, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina
,
Carina Paola RinaudoDepartment of Ophthalmology, Hospital de Clínicas José de San Martin, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina
&
Pablo ChiaradíaDepartment of Ophthalmology, Hospital de Clínicas José de San Martin, Universidad de Buenos Aires (UBA), Buenos Aires, Argentina
Pages 703-707 | Received 24 Mar 2018, Accepted 16 Apr 2019, Published online: 03 Jul 2019

References

  • Huang SX, Liang JL, Sui WG, et al. EDA mutation as a cause of hypohidrotic ectodermal dysplasia: a case report and review of the literature. Genet Macromol Res. 2015;14(3):10344–10351. doi:10.4238/2015.August.28.21.
  • KiShore M, Panat S, Aggarwal A, et al. Hypohidrotic ectodermal dysplasia (ED): a case series. J ClinDiagn Res. 2014;8(1):273–275. doi:10.7860/JCDR/2014/6597.3951.
  • Trzeciak WH, Koczorowski R. Molecular basis of hypohidrotic ectodermal dysplasia: an update. J Appl Genet. 2016;(57):51–61. doi:10.1007/s13353-015-0307-4.
  • Di Iorio E, Kaye SB, Ponzin D, et al. Limbal stem cells deficiency and ocular phenotype in ectrodactyly-ectodermal dysplasia-cleftings syndrome caused by p63 mutation. Ophthalmology. 2012;119(1):74–83. doi:10.1016/j.ophtha.2011.06.044.
  • Saw VPG, Dart JKG, Sitaru C, Zilliken D. Cicatrizing conjunctivitis with anti-basement membrane autoantibodies in ectodermal dysplasia. Br J Ophthalmol. 2008;92:1403–1410. doi:10.1136/bjo.2007.130583.
  • Georgoudis P, Sabatino F, Szentmary N, et al. Ocular mucous membrane pemphigoid: current state of pathophysiology, diagnostics and treatment. Ophthalmol Ther. 2019 Mar;8(1):5–17. doi:10.1007/s40123-019-0164-z.
  • Eschle-Meniconi ME, Ahmad SR, Foster CS. Mucous membrane pemphigoid: an update. Curr Opin Ophthalmol. Oct 2005;16(5):303–307.
  • Smith EP, Taylor TB, Meyer LJ, Zone JJ. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid. J Invest Dermatol. Oct 1993;101(4):619–623.
  • Dart JK. The 2016 bowman lecture conjunctival curses: scarring conjunctivitis 30 years on. Eye. 2017;31(2):301–332. doi:10.1038/eye.2016.284.
  • Olsen KE, Holland EJ. The association between ocular cicatricial pemphigoid and rheumatoid arthritis. Cornea. Sep 1998;17(5):504–507.
  • De Rojas MV, Dart JK, Saw VP. The natural history of Stevens–johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol. 2007 Aug;91(8):1048–1053. doi:10.1136/bjo.2006.109124.
  • Ebrahimiadib N, Hernandez M, Modjtahedi BS, Roohipoor CR, Foster CS. Atopy in patients with ocular cicatricial pemphigoid. Cornea. 2018 Apr;37(4):436–441. doi:10.1097/ICO.0000000000001477.
  • Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013 May-Jun;58(3):233–251. doi:10.1016/j.survophthal.2012.08.004.
  • Hung SO, Patterson A. Ectodermal dysplasia associated with autoimmune disease. Br J Ophthalmol. 1984;68:367–369.
  • O‘Gorman CS, Shulman R, Lara-Corrales I, et al. A child with autoimmune polyendocrinopathy candidiasis and ectodermal dysplasia treated with immunosuppression: a case report. J Med Case Rep. 2013 Feb;14(7):44. doi:10.1186/1752-1947-7-44.
  • Ma L, You C, Hernandez M, et al. Management of ocular cicatricial pemphigoid with intravenous immunoglobulin monotherapy. Ocul Immunol Inflamm. Mar 2018;8:1–7. doi:10.1080/09273948.2018.1433302.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.